- Study of genetic/epigenetic factors as biomarkers for diagnosing infertility, endometriosis, heart disease, stroke and stunting
- Study of infectious diseases and immune responses
- Study of natural ingredients on aging, non-communicable diseases (NCD), neuroprotective agents, and cancer
- Drug repurposing and new drug delivery systems
- Stem cells and regenerative medicine
- Determination and application of biomarkers for diagnostics of infertility, endometriosis, heart disease, stroke and stunting
- Community policy studies in infectious diseases
- Determination and application of natural product biomarkers in diagnostic aging and cancer
- Validation of various dosage forms, pharmacodynamic and safety tests in healthy humans
- Advanced clinical stem cell and organoid trials
- Sensitivity and specificity testing, development of AI and big Data applications in the discovery of new biomarkers and therapeutic targets for diagnostics of infertility, endometriosis, heart disease, stroke, and stunting
- Application of treating infectious diseases in the community, development of AI and Big Data applications in the discovery of new biomarkers and therapeutic targets for infectious diseases
- Determination and application of natural product biomarkers in the diagnosis of aging and cancer in populations, development of AI and Big Data in the discovery of new biomarkers and therapeutic targets for cancer
- Development of AI and Big Data health
- Application of various dosage forms for pharmacodynamic and safety tests in healthy humans
- Advanced clinical stem cell and organoid trials
-
- Standardization and evaluation of biomarker applications, AI, and Big Data applications in the discovery of biomarkers and new therapeutic targets for diagnostics of infertility, endometriosis, heart disease, stroke, and stunting
- Standardization and evaluation of disease management applications in communities, AI and big Data applications in the discovery of new biomarkers and therapeutic targets for infectious diseases
- Standardization and evaluation of applications, determination and application of natural product biomarkers, aging diagnostics, and cancer in populations, AI and Big Data applications in the discovery of biomarkers and new therapeutic targets for cancer
- Standardization and evaluation of health AI and Big Data
- Standardization and evaluation of the application of pharmacodynamic and safety test dosage forms in healthy humans
- Standardization and evaluation of advanced clinical stem cell and organoid trials
